Hematology NewsSen. Alexander seeks quick, passable steps to stabilize individual marketsSeptember 6, 2017Practice ManagementBusiness of Medicine
Oncology PracticeIs pain or dependency driving elevated opioid use among long-term cancer survivors?September 6, 2017GastroenterologyPatient & Survivor CareHodgkin LymphomaLung CancerGenitourinary CancerGynecologic CancerGastrointestinal Cancer
Hematology NewsHurricane Harvey tests Houston physicians’ mettleSeptember 6, 2017Practice ManagementBusiness of Medicine
Hematology TimesStudies of donor CAR T cells placed on holdSeptember 6, 2017Leukemia, Myelodysplasia, TransplantationAML
Hematology TimesFDA grants orphan designation to product for CMVSeptember 6, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
Hematology TimesFDA grants orphan designation to product for GVHDSeptember 6, 2017Leukemia, Myelodysplasia, TransplantationLymphoma & Plasma Cell DisordersMultiple MyelomaTransplantation
Hematology NewsTrump administration ends DACA program, stranding medical studentsSeptember 5, 2017Practice ManagementBusiness of Medicine
Oncology PracticePembrolizumab, nivolumab linked to 3% rate of neurologic eventsSeptember 5, 2017Immuno-oncologyPatient & Survivor CareHodgkin LymphomaMelanomaLung CancerRenal Cell CarcinomaHead & Neck/Thyroid Cancers
Hematology TimesPaper-based diagnostic device is like ‘portable lab’September 3, 2017AnemiaRelated Issues
Hematology TimesWithdrawn AML drug back on market in USSeptember 2, 2017Leukemia, Myelodysplasia, TransplantationPediatricsPharmacyAML
Hematology NewsFDA reapproves gemtuzumab ozogamicin for CD33-positive AML treatmentSeptember 1, 2017AMLLeukemia, Myelodysplasia, TransplantationPediatrics
Oncology PracticeMedicare fee schedule: Proposed pay bump falls short of promiseSeptember 1, 2017Business of MedicinePractice Management
